These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8093363)

  • 61. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial.
    Gottlieb MS; Zackin RA; Fiala M; Henry DH; Marcel AJ; Combs KL; Vieira J; Liebman HA; Cone LA; Hillman KS
    Ann Intern Med; 1991 Jul; 115(2):84-91. PubMed ID: 1676251
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Conjugates of 2',3'-didehydro-3'-deoxythymidine with thymogen. Synthesis and anti-HIV activity].
    Riakhovskiĭ VV; Malekin SI; Nosova VM; Kisin AV; Krugliak IuL; Kurochkin VK
    Bioorg Khim; 1999 Jul; 25(7):499-504. PubMed ID: 10563202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-performance liquid chromatographic determination of 2',3'-didehydro-3'-deoxythymidine (d4T) in human and rabbit plasma and urine and its application to pharmacokinetic studies in the rabbit.
    Wong SL; Sawchuk RJ
    Pharm Res; 1991 May; 8(5):619-23. PubMed ID: 1650942
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex.
    Pialoux G; Youle M; Dupont B; Gazzard B; Cauwenbergh GF; Stoffels PA; Davies S; de Saint Martin J; Janssen PA
    Lancet; 1991 Jul; 338(8760):140-3. PubMed ID: 1677064
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex.
    Folkers K; Hanioka T; Xia LJ; McRee JT; Langsjoen P
    Biochem Biophys Res Commun; 1991 Apr; 176(2):786-91. PubMed ID: 1673841
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rats.
    Boudinot FD; Smith SG; Funderburg ED; Schinazi RF
    Antimicrob Agents Chemother; 1991 Apr; 35(4):747-9. PubMed ID: 1648888
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analytical method for the quantification of 2',3'-didehydro-3'-deoxythymidine, a new anti-human immunodeficiency virus (HIV) agent, by high-performance liquid chromatography (HPLC) and ultraviolet (UV) detection in rat and monkey plasma.
    Kaul S; Dandekar KA; Pittman KA
    Pharm Res; 1989 Oct; 6(10):895-9. PubMed ID: 2558374
    [No Abstract]   [Full Text] [Related]  

  • 68. Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group.
    Gulevich SJ; Kalmijn JA; Thal LJ; Iragui-Madoz V; McCutchan JA; Kennedy C; Grant I
    Arch Neurol; 1992 Dec; 49(12):1281-4. PubMed ID: 1360202
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complex.
    Collier AC; Coombs RW; Katzenstein D; Holodniy M; Gibson J; Mordenti J; Izu AE; Duliege AM; Ammann AJ; Merigan T
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):150-6. PubMed ID: 7552478
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Short communication: possible activity of beta-carotene in patients with the AIDS related complex. A pilot study.
    Bianchi-Santamaria A; Fedeli S; Santamaria L
    Med Oncol Tumor Pharmacother; 1992; 9(3):151-3. PubMed ID: 1364129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study.
    Bisaccia E; Berger C; Klainer AS
    Ann Intern Med; 1990 Aug; 113(4):270-5. PubMed ID: 1973885
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies.
    Bilello JA; Bauer G; Dudley MN; Cole GA; Drusano GL
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1386-91. PubMed ID: 8092842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex.
    Mildvan D; Buzas J; Armstrong D; Antoniskis D; Sacks HS; Rhame FS; Mosbach EW; Pettinelli C
    J Acquir Immune Defic Syndr (1988); 1991; 4(10):945-51. PubMed ID: 1890604
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.
    Kaul S; Dandekar KA
    Antimicrob Agents Chemother; 1993 May; 37(5):1160-2. PubMed ID: 8390811
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study.
    Kahn JO; Kaplan LD; Gambertoglio JG; Bredesen D; Arri CJ; Turin L; Kibort T; Williams RL; Lifson JD; Volberding PA
    AIDS; 1990 Dec; 4(12):1197-204. PubMed ID: 2088398
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New AIDS drug passes first clinical test.
    Marx JL
    Science; 1989 Jul; 245(4916):353. PubMed ID: 2502839
    [No Abstract]   [Full Text] [Related]  

  • 77. HIV surrogate markers weighed.
    Cotton P
    JAMA; 1991 Mar; 265(11):1357, 1361-2. PubMed ID: 1671883
    [No Abstract]   [Full Text] [Related]  

  • 78. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.
    Schooley RT; Merigan TC; Gaut P; Hirsch MS; Holodniy M; Flynn T; Liu S; Byington RE; Henochowicz S; Gubish E
    Ann Intern Med; 1990 Feb; 112(4):247-53. PubMed ID: 2297203
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Considerations in the selection of end points for AIDS clinical trials.
    Amato DA; Lagakos SW
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S64-8. PubMed ID: 2121954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Surrogate markers in AIDS and cancer trials.
    Fleming TR
    Stat Med; 1994 Jul 15-30; 13(13-14):1423-35; discussion 1437-40. PubMed ID: 7973222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.